SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-009826
Filing Date
2024-07-16
Accepted
2024-07-16 07:01:19
Documents
15
Period of Report
2024-07-16
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pasg-20240716x8k.htm   iXBRL 8-K 44501
2 EX-99.1 pasg-20240716xex99d1.htm EX-99.1 21074
3 GRAPHIC pasg-20240716xex99d1001.jpg GRAPHIC 6265
  Complete submission text file 0001558370-24-009826.txt   205971

Data Files

Seq Description Document Type Size
4 EX-101.SCH pasg-20240716.xsd EX-101.SCH 3273
5 EX-101.LAB pasg-20240716_lab.xml EX-101.LAB 16579
6 EX-101.PRE pasg-20240716_pre.xml EX-101.PRE 10459
17 EXTRACTED XBRL INSTANCE DOCUMENT pasg-20240716x8k_htm.xml XML 5058
Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Filer) CIK: 0001787297 (see all company filings)

IRS No.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39231 | Film No.: 241118578
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)